Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05068063
Other study ID # IPACK1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2022
Est. completion date October 15, 2022

Study information

Verified date June 2022
Source University of Chile
Contact Sebastian L Layera, MD
Phone +562 29788221
Email sebastianlayera@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An adequate balance between analgesia and motor function is an essential requirement to facilitate functional recovery and early discharge after anterior cruciate ligament (ACL) reconstruction surgery. Proximal nerve blocks (i.e. femoral and sciatic nerve blocks) are associated with optimal analgesia, but they can cause muscle weakness, interfering with rehabilitation and increasing the risk of falls . A recent randomized controlled trial concluded that, compared to mid-and distal ACB, a distal femoral triangle block (FTB) is associated with lower opioid consumption and improved postoperative analgesia for ambulatory ACL reconstruction. In ACL reconstruction surgery there are other potential sources of pain not covered by a FTB, such as intra-articular structures (menisci, cruciate ligaments), posterior knee capsule and the graft donor site. Evidence supporting the addition of an IPACK block to a FTB has been studied for patients undergoing total knee replacement, nonetheless, there is no trial analyzing the analgesic contribution of IPACK to a FTB in the context of ACL reconstruction surgery. In this multicentric trial, the investigators set out to analyze the analgesic benefit of adding an IPACK block to a FTB.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date October 15, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patient scheduled to undergo anterior cruciate ligament reconstruction under general anesthesia with ipsilateral autologous graft. - Age between 18 and 65 years - American Society of Anesthesiologists classification 1-3 - Body mass index between 19 and 35 (kg/m2) Exclusion Criteria: - Adults who are unable to give their own consent - Pre-existing neuropathy (assessed by history and physical examination) - Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets = 100, International Normalized Ratio = 1.4 or prothrombin time = 50) - Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine = 100) - Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases = 100) - Allergy to local anesthetics (LAs), morphine or tramadol - Pregnancy - ACL revision surgery - Contralateral graft or any type of allograft - Chronic pain syndromes requiring opioid intake at home

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bupivacaine Injection
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of Bupivacaine 0.25%
normal Saline
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of normal saline 0.9%

Locations

Country Name City State
Chile Clinica Alemana de Santiago Santiago RM
Chile Hospital Clinico Universidad de Chile Santiago RM

Sponsors (2)

Lead Sponsor Collaborator
University of Chile Clinica Alemana de Santiago

Country where clinical trial is conducted

Chile, 

References & Publications (9)

Abdallah FW, Mejia J, Prasad GA, Moga R, Chahal J, Theodoropulos J, Dwyer T, Brull R. Opioid- and Motor-sparing with Proximal, Mid-, and Distal Locations for Adductor Canal Block in Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial. Anesthesiology. 2019 Sep;131(3):619-629. doi: 10.1097/ALN.0000000000002817. — View Citation

Abdallah FW, Whelan DB, Chan VW, Prasad GA, Endersby RV, Theodoropolous J, Oldfield S, Oh J, Brull R. Adductor Canal Block Provides Noninferior Analgesia and Superior Quadriceps Strength Compared with Femoral Nerve Block in Anterior Cruciate Ligament Reconstruction. Anesthesiology. 2016 May;124(5):1053-64. doi: 10.1097/ALN.0000000000001045. — View Citation

Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Redefining the adductor canal block. Reg Anesth Pain Med. 2014 Sep-Oct;39(5):442-3. doi: 10.1097/AAP.0000000000000119. — View Citation

Bushnell BD, Sakryd G, Noonan TJ. Hamstring donor-site block: evaluation of pain control after anterior cruciate ligament reconstruction. Arthroscopy. 2010 Jul;26(7):894-900. doi: 10.1016/j.arthro.2009.11.022. Epub 2010 May 13. — View Citation

Chan E, Howle R, Onwochei D, Desai N. Infiltration between the popliteal artery and the capsule of the knee (IPACK) block in knee surgery: a narrative review. Reg Anesth Pain Med. 2021 Sep;46(9):784-805. doi: 10.1136/rapm-2021-102681. Epub 2021 May 14. Review. — View Citation

Johnston DF, Black ND, Cowden R, Turbitt L, Taylor S. Spread of dye injectate in the distal femoral triangle versus the distal adductor canal: a cadaveric study. Reg Anesth Pain Med. 2019 Jan;44(1):39-45. doi: 10.1136/rapm-2018-000002. — View Citation

Johnston DF, Sondekoppam RV, Uppal V, Litchfield R, Giffin R, Ganapathy S. Effect of combining peri-hamstring injection or anterior obturator nerve block on the analgesic efficacy of adductor canal block for anterior cruciate ligament reconstruction: a randomised controlled trial. Br J Anaesth. 2020 Mar;124(3):299-307. doi: 10.1016/j.bja.2019.11.032. Epub 2020 Jan 21. — View Citation

Sharma S, Iorio R, Specht LM, Davies-Lepie S, Healy WL. Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468(1):135-40. doi: 10.1007/s11999-009-1025-1. Epub 2009 Aug 13. — View Citation

Wilde J, Bedi A, Altchek DW. Revision anterior cruciate ligament reconstruction. Sports Health. 2014 Nov;6(6):504-18. doi: 10.1177/1941738113500910. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Post-operative pain scores at 2 hours of arrival to Post Anesthesia Care Unit (PACU) Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points 2 hours after arrival to PACU
Secondary Post-operative static pain scores at 0 hours of arrival to PACU Pain evaluated at rest in Numeric Rating Score from 0 to 10 points 0 hours after arrival to PACU
Secondary Post-operative static pain scores at PACU discharge Pain evaluated at rest in Numeric Rating Score from 0 to 10 points at discharge of PACU up to 2 hours postoperatively
Secondary Post-operative static pain scores at 6 hours of arrival to PACU Pain evaluated at rest in Numeric Rating Score from 0 to 10 points 6 hours after arrival to PACU
Secondary Post-operative static pain scores at 12 hours of arrival to PACU Pain evaluated at rest in Numeric Rating Score from 0 to 10 points 12 hours after arrival to PACU
Secondary Post-operative static pain scores at 24 hours of arrival to PACU Pain evaluated at rest in Numeric Rating Score from 0 to 10 points 24 hours after arrival to PACU
Secondary Post-operative dynamic pain scores at 0 hours of arrival to PACU Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points 0 hours after arrival to PACU
Secondary Post-operative dynamic pain scores at PACU discharge Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points at discharge of PACU up to 2 hours postoperatively
Secondary Post-operative dynamic pain scores at 6 hours of arrival to PACU Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points 6 hours after arrival to PACU
Secondary Post-operative dynamic pain scores at 12 hours of arrival to PACU Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points 12 hours after arrival to PACU
Secondary Post-operative dynamic pain scores at 24 hours of arrival to PACU Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points 24 hours after arrival to PACU
Secondary Femoral Triangle Block success assessment at 2 hours Sensory block will be assessed with ice on the medial leg 2 hours after arrival to PACU
Secondary Incidence of opioid related adverse events Incidence of adverse events related to opioid use (nausea/vomiting, pruritus, somnolence, respiratory depression, urinary retention) 24 hours after arrival to PACU
Secondary Intraoperative opioid consumption Total opioid use during intraoperative period From anesthesia induction to extubation
Secondary PACU opioid consumption total opioid consumption during PACU stay from PACU arrival to discharge up to 2 hours postoperatively
Secondary Total opioid consumption Total opioid consumption 6 hours, 12 hours and 24 hours after PACU arrival
Secondary Nerve block complications Incidence of nerve block complications (vascular puncture, puncture site erythema, hematoma, foot drop, LAST) From nerve block performance up to 24 hours after PACU arrival
Secondary Lower limb tourniquet lower limb tourniquet duration from inflation of pneumatic device to tourniquet release
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Recruiting NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2